台湾多中心注册研究:房颤冷冻球囊消融术后24个月复发预测因素与生活质量
该研究基于台湾4家三级中心298例以阵发性房颤为主的患者,评估冷冻球囊消融术后24个月心律失常复发及12个月生活质量。结果显示手术相关不良事件发生率2.0%,空白期后19%患者记录到复发,诊断至消融时间越长独立预测复发;配对生活质量数据中EQ-5D-3L指数无显著变化,但VAS症状负担类别向低负担偏移。
要点
- 冷冻球囊消融安全,不良事件率2.0%,无心脏压塞或房食管瘘。
- 空白期后19%患者记录到复发,24个月无复发生存约62%。
- 诊断至消融时间每延长1年,复发风险独立增加(调整HR 1.050)。
核心结论
- 在以阵发性房颤为主的台湾多中心注册中,冷冻球囊消融并发症率低,间歇监测下12个月无记录心律失常生存约90%。
- 诊断至消融时间较长独立预测复发,左室射血分数呈边缘性负相关。
- 配对生活质量分析中EQ-5D-3L指数无显著变化,但VAS症状负担类别向低负担偏移,34%患者VAS改善≥10分。
研究设计与样本
- 台湾4家三级中心2018–2023年前瞻性多中心注册,连续纳入298例接受冷冻球囊消融的房颤患者。
- 94.6%(282/298)为阵发性房颤,年龄63.7±11.8岁,男性60%。
- 复发定义为90天空白期后记录到≥30秒房性心律失常事件,随访主要依赖间歇心电图、动态心电图、事件记录器或临床指征性节律评估。
- 生活质量采用EQ-5D-3L指数和视觉模拟量表(VAS),分析基于205/298例配对完整病例数据。
主要发现
- 手术相关不良事件发生率为2.0%,无心脏压塞或房食管瘘。
- 间歇监测下Kaplan–Meier无复发生存12个月约90%,24个月约62%,18个月后置信带增宽。
- 多变量分析中,诊断至消融时间较长独立预测复发(调整HR 1.050/年,95%CI 1.007–1.096;p=0.023)。
- 左室射血分数与复发呈边缘性负相关(调整HR 0.970/1%,95%CI 0.942–1.000;p=0.052)。
关键数值与推荐
- 复发定义:90天空白期后记录到≥30秒房性心律失常事件。
- 临床有意义VAS改善定义为≥10分。
- 诊断至消融时间每延长1年,复发调整HR 1.050(95%CI 1.007–1.096;p=0.023)。
- 左室射血分数每增加1%,复发调整HR 0.970(95%CI 0.942–1.000;p=0.052)。
临床怎么用
- 冷冻球囊消融在阵发性房颤中安全有效,12个月无记录心律失常生存约90%,可用于评估手术预期。
- 诊断至消融时间较长提示复发风险较高,应尽早考虑消融以改善节律结局。
- 尽管EQ-5D-3L指数未变,VAS显示约三分之一患者症状负担有临床意义改善,提示需结合症状量表评估获益。
- 间歇监测下24个月无复发生存约62%,随访超过18个月时置信区间增宽,解读长期成功率需谨慎。
局限性
- 节律随访主要依赖间歇监测,可能低估无症状或未记录到的复发。
- 生活质量配对数据仅205/298例完整,缺失可能影响结果代表性。
- VAS改善的逻辑模型因事件稀疏和准完全分离不稳定,未能确认独立预测因素。
- 研究以阵发性房颤为主(94.6%),结果推广至持续性房颤需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 298 patients from a Taiwanese multicenter registry, cryoballoon ablation for AF was safe (2.0% adverse events). About 81% of patients stayed free of arrhythmia recurrence through 24 months. Longer AF duration before the procedure predicted recurrence. One-third of patients had meaningful symptom improvement on the VAS, but the EQ-5D-3L index did not change. ABSTRACT Background Contemporary Asian data on 24-month outcomes after cryoballoon ablation (CBA) in predominantly paroxysmal atrial fibrillation (AF) are limited. Methods We conducted a multicenter registry across four Taiwanese tertiary centers (2018–2023). Consecutive patients undergoing CBA were analyzed for documented atrial-arrhythmia recurrence (≥ 30-s episodes after a 90-day blanking period) and 12-month quality of life (QoL; EQ-5D-3L index and visual analogue scale [VAS]). Rhythm follow-up relied mainly on intermittent ECG, Holter, event-recorder, or clinically indicated rhythm assessment. Cox models identified recurrence predictors; QoL analyses used paired complete-case data. Results Among 298 patients (age 63.7 ± 11.8 years, 60% men), 282 (94.6%) had paroxysmal AF. Procedure-related adverse events were rare (2.0%), with no tamponade or atrioesophageal fistula. Fifty-eight patients (19%) had post-blanking documented recurrence (late 90–365 days: n = 37; very late > 365 days: n = 21). Kaplan–Meier recurrence-free survival under intermittent monitoring was approximately 90% at 12 months and 62% at 24 months, with wider confidence bands beyond 18 months. In multivariable analysis, longer time from AF diagnosis to ablation independently predicted recurrence (adjusted HR 1.050 per year, 95% CI 1.007–1.096; p = 0.023); left-ventricular ejection fraction showed a borderline inverse association (adjusted HR 0.970 per 1%, 95% CI 0.942–1.000; p = 0.052). QoL analyses in 205/298 patients with paired data showed no significant change in EQ-5D-3L index (p = 0.672), but VAS categories shifted toward lower symptom burden (moderate/high 21.5% to 10.2%). A clinically meaningful VAS improvement (≥ 10 points) occurred in 34% (70/205). Because paired QoL data were incomplete and the logistic model was unstable owing to sparse events and quasi-complete separation, no robust independent predictor of VAS improvement could be confirmed. Conclusion In this multicenter Taiwanese registry of predominantly paroxysmal AF, CBA had a low complication rate and high 12-month freedom from documented arrhythmia under interm
引用
- Journal of Cardiovascular Electrophysiology:Predictors of Recurrence and Quality of Life After Cryoballoon Ablation in Atrial Fibrillation: Data From a Multicenter Taiwanese Registry With 24‐Month Follow‐Up
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。